Search Results - "Joubran, Salim"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Enhancing the Efficiency of the Solid Phase Peptide Synthesis (SPPS) Process by High Shear Mixing by Alshanski, Israel, Bentolila, Moshe, Gitlin-Domagalska, Agata, Zamir, Dolev, Zorsky, Shir, Joubran, Salim, Hurevich, Mattan, Gilon, Chaim

    Published in Organic process research & development (21-09-2018)
    “…The brittle nature of the polymer beads used in SPPS dictates mild mixing techniques with low mass transfer. We demonstrate that vigorous overhead mechanical…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Optimization of Liganded Polyethylenimine Polyethylene Glycol Vector for Nucleic Acid Delivery by Joubran, Salim, Zigler, Maya, Pessah, Neta, Klein, Shoshana, Shir, Alexei, Edinger, Nufar, Sagalov, Anna, Razvag, Yair, Reches, Meital, Levitzki, Alexander

    Published in Bioconjugate chemistry (17-09-2014)
    “…The delivery of nucleic acids into cells is an attractive approach for cancer therapy. Polyethylenimine (PEI) is among the most efficient nonviral carriers…”
    Get full text
    Journal Article
  4. 4

    Superiority of the S,S conformation in diverse pharmacological processes: Intestinal transport and entry inhibition activity of novel anti-HIV drug lead by Fanous, Joseph, Swed, Avi, Joubran, Salim, Hurevich, Mattan, Britan-Rosich, Elena, Kotler, Moshe, Gilon, Chaim, Hoffman, Amnon

    Published in International journal of pharmaceutics (30-11-2015)
    “…[Display omitted] Chirality is an important aspect in many pharmacological processes including drug transport and metabolism. The current investigation…”
    Get full text
    Journal Article
  5. 5

    Abstract B243: Targeting HER-2 positive breast cancer by inducing apoptosis and immune cell activation, overcoming trastuzumab resistance by Zigler, Maya, Joubran, Salim, Shir, Alexei, Edinger, Noofar, Klein, Shoshana, Levitzki, Alexander

    Published in Molecular cancer therapeutics (01-11-2013)
    “…Abstract Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths in females. Overexpression of HER-2 occurs in…”
    Get full text
    Journal Article
  6. 6

    HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment by Zigler, Maya, Shir, Alexei, Joubran, Salim, Sagalov, Anna, Klein, Shoshana, Edinger, Nufar, Lau, Jeffrey, Yu, Shang-Fan, Mizraji, Gabriel, Globerson Levin, Anat, Sliwkowski, Mark X, Levitzki, Alexander

    Published in Cancer immunology research (01-08-2016)
    “…The development of targeted therapies that affect multiple signaling pathways and stimulate antitumor immunity is greatly needed. About 20% of patients with…”
    Get more information
    Journal Article
  7. 7